*3.2. Toxicity*

No severe adverse events associated with the vaccine were observed. During the vaccination therapy, skin flare (grade 1) was shown in one patient and induration (grade 1) was shown in five patients at the injection site. Wound infection (grade 2) and herpes zoster (grade 2) were each found in a single patient during the observation period and were considered to be unrelated to the vaccination.
